Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease Review uri icon

Overview

MeSH Major

  • Coronary Disease
  • Fibrinolysis
  • Plasminogen Activator Inhibitor 1

abstract

  • Our study indicates a causal effect of elevated PAI-1 level on CHD risk, which may be mediated by glucose dysfunction.

authors

publication date

  • June 2017

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC5669150

Digital Object Identifier (DOI)

  • 10.1161/JAHA.116.004918

PubMed ID

  • 28550093

Additional Document Info

volume

  • 6

number

  • 6